Lupin Ltd.

₹2093.2

Lupin Ltd.

₹2093.2

₹2093.2

26.1 (1.26%) - 30 Apr 2025 01:35 PM

About Company

Lupin Limited is an innovation led Transnational Pharmaceutical Company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally. It has significant presence in the Cardiovascular, Diabetology, Asthama, Pediatrics, Central Nervous System, Gastro-Intestinal, AntiInfectives and Nonsteroidal Anti Inflammatory Drug therapy segments and is a global leader in the Anti-TB and Cephalosporins segments. The company along with its subsidiaries has manufacturing locations spread across India, USA, Mexico and Brazil with trading and other incidental and related activities extending to the global markets.

Market Cap. ₹94,387 Cr.
52 Week - High/Low ₹2,403/1,493
P/E Ratio 30.75
P/B Ratio 4.58
Enterprise Value ₹94,859 Cr.
ROE % 12.0
RSI Value 53.36
EMA 50 2032.33
EMA 200 1991.66
Market Cap. ₹94,387 Cr.
52 Week - High/Low ₹2,403/1,493
P/E Ratio 32.87
P/B Ratio 6.60
Enterprise Value ₹93,989 Cr.
ROE % 14.61
RSI Value 53.36
EMA 50 2032.33
EMA 200 1991.66

Growth

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.